60m more vaccine doses secured for booster programme
- Credit: Stefan Rousseau/PA Wire
A further 60m Pfizer vaccines have been secured as part of the government's booster vaccine programme.
Matt Hancock, the health secretary made the announcement during a briefing on Wednesday evening.
The UK has purchased 517m doses of eight different vaccines.
Matt Hancock said: "Our vaccination programme is bringing back our freedom, but the biggest risk to that progress is the risk posed by a new variant.
“These further 60 million doses will be used, alongside others, as part of our booster programme from later this year, so we can protect the progress that we’ve all made."
The minister announced that he will be having his first coronavirus vaccine on Thursday, reiterating the message of the new government campaign "every vaccination brings us hope".
Mr Hancock said the UK was on track for the easing measures due to come into effect on May 17, which will include allowing some indoor mixing between households, next month.
- 1 Norfolk village named among poshest places to live in the UK
- 2 Couple explores Norfolk homes in Escape to the Country
- 3 What is this mystery tower that has sprung up in Norwich?
- 4 'Fantastic, loving, cheeky' 19-year-old killed in motorbike crash
- 5 Drunk student crashed into hotel wall after drinking tequilas
- 6 'Ghetto' fears raised over scheme for 725 new homes
- 7 Pub landlord threatened to kill man he chased through streets with axe
- 8 MAPPED: Where thousands of homes could be built in north Norfolk
- 9 'Once in a lifetime catch' - man lands monster fish in Norfolk
- 10 Seven Sprowston neighbours scoop £30,000 lottery win
He said: "The good news is that as far as the next step is concerned, which is in a few weeks' time - and we're going to keep monitoring the data - but as of today, we are on track for step three on May 17 and that is good news."
Professor Jonathan Van-Tam, deputy chief medical officer for England, said that during the peak in early 2021 not many people were vaccinated so the drop in cases, people in hospital and deaths was due to the efforts of the British public - with vaccines "undoubtedly" helping in later stages.
He added: "What is important about these vaccines and the vaccine rollout is it really is the way out of getting into trouble of the same size and magnitude ever again, and that's why it's important that this job must get finished."
Further details about the boost programme will be release in due course using advice from the Joint Committee on Vaccination and Immunisation (JCVI) and results of trials looking into the combinations of approved vaccines.
More than 47.5m people have had a vaccination, with a quarter of all adults having both doses.
Reviews are underway to assess two other vaccines with ongoing clinical trials for the Valneva, GSK and Sanofi and CureVac jabs.